Page 2 - Polypeptide Group News Today

PolyPeptide Group / Key word: Financing PolyPeptide secures revolving credit facility 02.10.2023 / 07:00 CET/CEST Media Release PolyPeptide secures revolving...

Dublin, Aug. 30, 2023 (GLOBE NEWSWIRE) -- The "Global Peptide Therapeutics Market (2023-2028) by Synthesis Technology, Drug Class, Route of...

PolyPeptide Group ( VTX:PPGN ) First Half 2023 Results Key Financial Results Revenue: €131.8m (down 1.4% from 1H 2022...

PolyPeptide Group / Key word(s): Half Year Results Transformational progress taking shape, profitability impacted by rapid expans...

PolyPeptide Group Key word Half Year Results Transformational progress taking shape profitability impacted by rapid expansion – appointment of Marc Augustin as new CFO 15Aug2023 0700 CETCEST Release

Polypeptide Labs Inc. has agreed to pay $57,472 for violating the Resource Conservation and Recovery Act.

PolyPeptide Group Key word Profit Warning PolyPeptide delivers revenue of around EUR 132 million for H1 – expects net loss for H1 and full year 2023 13Jul2023 0700 CETCEST Release of an ad hoc announ

PolyPeptide Group's (VTX:PPGN) stock is up by a considerable 18% over the past three months. But the company's key...

Lund, June 12, Hamlet Pharma, ticker HAMLET, soon to be Hamlet BioPharma, the innovative pharmaceutical company with a strong portfolio of projects for the treatment of cancer and infections, announces that Hamlet Pharma has extended and expanded the agreement with the Swiss public company Polypeptide Group, ticker PPGN, to produce larger quantities of the synthetic peptide Alpha1. The new production, at a larger scale, will be essential for future expansions of the clinical trial program in bla...

Dublin, May 25, 2023 (GLOBE NEWSWIRE) -- The "Peptide Therapeutics Market, By Product Type, By Application, By Route of Administration, and By Region -...